Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 68 M74 M67 M68 M69 M 278 M Research & development ————— — Operating income 284 M512 M243 M449 M281 M 1.49 B Non-Operating Income, Total ————— — Interest expense, net of interest capitalized 222 M218 M220 M225 M217 M 880 M Non-Operating Income, excl. Interest Expenses ————— — Unusual income/expense ————— — Pretax income 67 M438 M-2 M221 M64 M 721 M Equity in earnings 2 M2 M4 M1 M4 M 11 M Taxes 42 M118 M-173 M61 M89 M 95 M Non-controlling/minority interest 38 M38 M41 M50 M33 M 162 M After tax other income/expense -45 M-47 M-42 M-39 M-40 M -168 M Net income before discontinued operations -13 M282 M130 M110 M-58 M 464 M Discontinued operations ————— — Net income -13 M282 M130 M110 M-58 M 464 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -13 M282 M130 M110 M-58 M 464 M Basic earnings per share (Basic EPS) -0.12.110.970.83-0.43 3.48 Diluted earnings per share (Diluted EPS) -0.12.090.960.82-0.43 3.44 Average basic shares outstanding 132.88 M133.76 M133.79 M133.56 M134.42 M — Diluted shares outstanding 132.88 M134.88 M135.19 M135.01 M134.42 M — EBITDA 286 M514 M245 M452 M283 M 1.49 B EBIT 284 M512 M243 M449 M281 M 1.49 B Cost of revenue 489 M469 M460 M446 M441 M 1.82 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 2 M3 M2 M2 M2 M 9 M